文献速递临床试验与 GCP

内界膜翻转插入联合空气填充治疗高度近视黄斑裂孔视网膜脱离:随机对照试验方案

Inverted internal limiting membrane insertion combined with air tamponade in the treatment of macular hole retinal detachment in high myopia: study protocol for a randomized controlled clinical trial.
PubMed 文献 · Trials · 2018-08-30

本研究为随机对照临床试验方案,计划纳入38例高度近视黄斑裂孔视网膜脱离患者,随机分为两组:一组采用玻璃体切除联合内界膜剥除及硅油填充,另一组采用玻璃体切除联合内界膜剥除、内界膜翻转插入及空气填充。主要结局为术后3个月黄斑裂孔闭合率,次要结局包括最佳矫正视力、视网膜脱离复位率及术后并发症发生率。

要点

  • 内界膜翻转插入联合空气填充可能为高度近视黄斑裂孔视网膜脱离提供新术式。
  • 主要结局指标为术后3个月黄斑裂孔闭合率。
  • 次要结局包括最佳矫正视力、视网膜脱离复位率及并发症发生率。

核心结论

  • 该试验旨在评估内界膜翻转插入联合空气填充治疗高度近视黄斑裂孔视网膜脱离的疗效与安全性,并与传统玻璃体切除联合内界膜剥除及硅油填充方法进行比较。

研究设计与样本

  • 随机对照临床试验,计划纳入38例高度近视黄斑裂孔视网膜脱离患者,随机分为两组。
  • 组1:标准三通道23G玻璃体切除联合内界膜剥除、气液交换及硅油填充。
  • 组2:标准三通道23G玻璃体切除联合内界膜剥除、内界膜翻转插入及气液交换。

主要发现

  • 主要结局为初次手术后3个月黄斑裂孔闭合率。
  • 次要结局包括最佳矫正视力、视网膜脱离复位率及术后并发症发生率。

临床怎么用

  • 该试验结果可能为高度近视黄斑裂孔视网膜脱离提供更有效、痛苦更少的新型手术方式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Macular hole retinal detachment (MHRD) occurs most commonly in high myopia and causes severe visual impairment and greatly reduces the quality of life. The aim of this study is to evaluate the efficacy and safety of inverted internal limiting membrane insertion combined with air tamponade in the treatment of MHRD in high myopia, and also to compare the treatment efficacy with that of the conventional "vitrectomy plus internal limiting membrane peeling plus silicone oil tamponade" method for high myopia-associated MHRD. METHODS/DESIGN: In this clinical trial, 38 patients with MHRD in high myopia will be randomly assigned to two groups (Group 1: standard 3-port 23-gauge pars plana vitrectomy plus internal limiting membrane peeling plus air-fluid exchange plus silicone oil infusion; Group 2: standard 3-port 23-gauge pars plana vitrectomy plus internal limiting membrane peeling plus inverted internal limiting membrane insertion plus air-fluid exchange). The primary outcome is macular hole closure rate in 3 months after the initial surgery. The secondary outcomes are best corrected visual acuity (BCVA), reattachment rate of retinal detachment, and postoperative complication rate. DISCUSSION: The study results may help to evaluate the efficacy and safety of inverted internal limiting membrane insertion combined with air tamponade in the treatment of MHRD in high myopia, and also compare the efficacy of the new treatment with the conventional "vitrectomy plus internal limiting membrane peeling plus silicone oil tamponade" method. This trial may provide a novel surgical treatment for MHRD in high myopia with more effectiveness and less pain. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03383731 . Registered on 19 December 2017. Retrospectively registered.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Zheng Y, Kang M, Wang H, et al. Inverted internal limiting membrane insertion combined with air tamponade in the treatment of macular hole retinal detachment in high myopia: study protocol for a randomized controlled clinical trial. Trials. 2018. PMID: 30165894. doi:10.1186/s13063-018-2833-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。